For more than 40 years, Genentech has pursued groundbreaking science to discover and develop innovative medicines for people facing serious and life-threatening diseases.

Genentech became a member of the Roche Group in 2009. For decades, Roche has been conducting neuroscience research and clinical trials aimed at exploring areas of the highest medical need.


To reach medical information:

If you are an individual living outside of the United States or Canada: